CHARLOTTE, N.C., July 21, 2026 (GLOBE NEWSWIRE) — DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, August 6, 2026, at 4:30 p.m. ET to review its second quarter 2026 financial results. Financial earnings materials will be made available on the Investors section of the Company’s website at https://investor.dentsplysirona.com prior to the call.
Conference Call / Webcast Information
The live webcast link and call information will be available on the Investors section of the Company’s website at https://investor.dentsplysirona.com. For those planning to participate on the call, please register here. A webcast replay of the conference call will be available on the Investors section of the Company’s website following the call.
About Dentsply Sirona
Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands. Dentsply Sirona’s innovative products provide high-quality, effective and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona is headquartered in Charlotte, North Carolina. The Company’s shares are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.
Contact Information
Investors:
Wade Moody
Senior Manager, Investor Relations
Investorrelations@dentsplysirona.com
The article outlines how gentle chiropractic techniques support spinal alignment and movement in children and…
Collaboration creates a path to combine Signant's market-leading eCOA and digital endpoint capabilities with Lothar…
Amwell® is transforming virtual care delivery through its unified Amwell Platform, combining interoperability, clinical integration,…
US-based research peptide supplier broadens third-party analytical testing and per-batch Certificate of Analysis documentation across…
Montreal, Quebec--(Newsfile Corp. - September 4, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE:…
Accreditation affirms MMRO's commitment to responsible AI governance, human oversight, and clinical integrity.NOVI, Mich., Sept.…